Recombinant Human CD40L/TNFSF5 Protein (E.coli)
Recombinant Human CD40L/TNFSF5 Protein (E.coli) supplied by Elabscience with collaborator-provided technical specifications. Read more ›
["Measure by its ability to induce IL-8 secretion in human PBMCs. The ED50 for this effect is <5 ng/mL. ,16 kDa"]Product Description
CD40L is the stated recombinant protein target for this Elabscience product. The listing uses collaborator-supplied specifications to support research-use-only protein selection through ABMIUM.
Protein profile: reactive species/source: Human; expression system: E.coli; physical form: Lyophilized from sterile PBS,pH 8.0.<br/>Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization.<br/>Please refer to the specific buffer information in the printed manual.; tag: Human ,CD40L ,Recombinant Proteins; predicted molecular weight: 17.0 kDa.
Quality and formulation: purity: > 95 % as determined by reducing SDS-PAGE.; endotoxin: < 0.1 EU per μg of the protein as determined by the LAL method..
Functional evidence: activity: Measure by its ability to induce IL-8 secretion in human PBMCs. The ED<sub>50</sub> for this effect is <5 ng/mL.. In the ABMIUM matrix, collaborator-supplied functional evidence is marked C; unsupported application columns remain N.
Sequence coverage: 17.0 kDa.
Database references: UniProt: P29965 | NCBI Gene: 959 | Gene symbol: CD40L.
Research Use Only.
Key Facts
| Target | CD40L |
| Also known as | CD154, CD40 Ligand, CD40-L, CD40L, CD40LG, HIGM1, IGM, IMD3, T-BAM, T-Cell Antigen Gp39, TNF-Related Activation Protein, TNFSF5, TRAP, Tumor Necrosis Factor Ligand Superfamily Member 5, hCD40L |
| Species reactivity | Human |
| Purity | > 95 % as determined by reducing SDS-PAGE. |
| Form / buffer | Lyophilized from sterile PBS,pH 8.0. Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization. Please refer to the specific buffer information in the printed manual. |
| Shelf life | 12 months |
| Research area | Cardiovascular, immunology |
| BIOACTIVITY | BINDING | CELL-BASED | IN VIVO | ELISA CAPTURE | |
|---|---|---|---|---|---|
| Human |
Specifications
Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the printed manual.
Storage & Stability
Compliance & Certifications
Manufactured under ISO 9001:2015 quality management standards.
Manufactured under ISO 14001:2015 quality management standards.
Manufactured under ISO 45001:2018 quality management standards.
Not intended for diagnostic or therapeutic use.
Substance does not appear on the SVHC candidate list.